Welcome!

Cloud Expo Authors: Dana Gardner, Elizabeth White, Noel Wurst, Liz McMillan, Unitiv Blog

Related Topics: Cloud Expo, Java, SOA & WOA, Open Source, Web 2.0, Apache

Cloud Expo: Article

The Cure for the Common Cloud-Based Big Data Initiative

Understanding how to work with Big Data

There is no doubt that Big Data holds infinite promise for a range of industries. Better visibility into data across various sources enables everything from insight into saving electricity to agricultural yield to placement of ads on Google. But when it comes to deriving value from data, no industry has been doing it as long or with as much rigor as clinical researchers.

Unlike other markets that are delving into Big Data for the first time and don't know where to begin, drug and device developers have spent years refining complex processes for asking very specific questions with clear purposes and goals. Whether using data for designing an effective and safe treatment for cholesterol, or collecting and mining data to understand proper dosage of cancer drugs, life sciences has had to dot every "i" and cross every "t" in order to keep people safe and for new therapies to pass muster with the FDA. Other industries are now marveling at a new ability to uncover information about efficiencies and cost savings, but - with less than rigorous processes in place - they are often shooting in the dark or only scratching the surface of what Big Data offers.

Drug developers today are standing on the shoulders of those who created, tested and secured FDA approval for treatments involving millions of data points (for one drug alone!) without the luxury of the cloud or sophisticated analytics systems. These systems have the potential to make the best data-driven industry even better. This article will outline key lessons and real-world examples of what other industries can and should learn from life sciences when it comes to understanding how to work with Big Data.

What Questions to Ask, What Data to Collect
In order to gain valuable insights from Big Data, there are two absolute requirements that must be met - understanding both what questions to ask and what data to collect. These two components are symbiotic, and understanding both fully is difficult, requiring both domain expertise and practical experience.

In order to know what data to collect, you first must know the types of questions that you're going to want to ask - often an enigma. With the appropriate planning and experience-based guesses, you can often make educated assumptions. The trick to collecting data is that you need to collect enough to answer questions, but if you collect too much then you may not be able to distill the specific subset that will answer your questions. Also, explicit or inherent cost can prevent you from collecting all possible data, in which case you need to carefully select which areas to collect data about.

Let's take a look at how this is done in clinical trials. Say you're designing a clinical study that will analyze cancer data. You may not have specific questions when the study is being designed, but it's reasonable to assume that you'll want to collect data related to commonly impacted readings for the type of cancer and whatever body system is affected, so that you have the right information to analyze when it comes time.

You may also want to collect data unrelated to the specific disease that subsequent questions will likely require, such as information on demographics and medications that the patient is taking that are different from the treatment. During the post-study data analysis, questions on these areas often arise, even though the questions aren't initially apparent. Thus clinical researchers have adopted common processes for collecting data on demographics and concomitant medications. Through planning and experience, you can also identify areas that do not need to be collected for each study. For example, if you're studying lung cancer, collecting cognitive function data is probably unrelated.

How can other industries anticipate what questions to ask, as is done in life sciences? Well, determine a predefined set of questions that are directly related to the goal of the data analysis. Since you will not know all of the questions until after the data collection have started, it's important to 1) know the domain, and 2) collect any data you'll need to answer the likely questions that could come up.

Also, clinical researchers have learned that questions can be discovered automatically. There are data mining techniques that can uncover statistically significant connections, which in effect are raising questions that can be explored in more detail afterwards. An analysis can be planned before data is collected, but not actually be run until afterwards (or potentially during), if the appropriate data is collected.

One other area that has proven to be extremely important to collect is metadata, or data about the data - such as, when it was collected, where it was collected, what instrumentation was used in the process and what calibration information was available. All of this information can be utilized later on to answer a lot of potentially important questions. Maybe there was a specific instrument that was incorrectly configured and all the resulting data that it recorded is invalid. If you're running an ad network, maybe there's a specific web site where your ads are run that are gaming the system trying to get you to pay more. If you're running a minor league team, maybe there's a specific referee that's biased, which you can address for subsequent games. Or, if you're plotting oil reserves in the Gulf of Mexico, maybe there are certain exploratory vessels that are taking advantage of you. In all of these cases, without the appropriate metadata, it'd be impossible to know where real problems reside.

Identifying Touch Points to Be Reviewed Along the Way
There are ways to specify which types of analysis can be performed, even while data is being collected, that can affect either how data will continue to be collected or the outcome as a whole.

For example, some clinical studies run what's called interim analysis while the study is in progress. These interim analyses are planned, and the various courses that can be used afterwards are well defined, but the results afterward are statistically usable. This is called an adaptive clinical trial, and there are a lot of studies that are being performed to determine more effective and useful ways that these can be done in the future. The most important aspect of these is preventing biases, and this is something that has been well understood and tested by the pharmaceutical community over the past several decades. Simply understanding what's happening during the course of a trial, or how it affects the desired outcome, can actually bias the results.

The other key factor is that the touch points are accessible to everybody who needs the data. For example, if you have a person in the field, then it's important to have him or her access the data in a format that's easily consumable to them - maybe through an iPad or an existing intranet portal. Similarly, if you have an executive that needs to understand something at a high level, then getting it to them in an easily consumable executive dashboard is extremely important.

As the life sciences industry has learned, if the distribution channels of the analytics aren't seamless and frictionless, then they won't be utilized to their fullest extent. This is where cloud-based analytics become exceptionally powerful - the cloud makes it much easier to integrate analytics into every user's day. Once each user gets the exact information they need, effortlessly, they can then do their job better and the entire organization will work better - regardless of how and why the tools are being used.

Augmenting Human Intuition
Think about the different types of tools that people use on a daily basis. People use wrenches to help turn screws, cars to get to places faster and word processers to write. Sure, we can use our hands or walk, but we're much more efficient and better when we can use tools.

Cloud-based analytics is a tool that enables everybody in an organization to perform more efficiently and effectively. The first example of this type of augmentation in the life sciences industry is alerting. A user tells the computer what they want to see, and then the computer alerts them via email or text message when the situation arises. Users can set rules for the data it wants to see, and then the tools keep on the lookout to notify the user when the data they are looking for becomes available.

Another area the pharmaceutical industry has thoroughly explored is data-driven collaboration techniques. In the clinical trial process, there are many different groups of users: those who are physically collecting the data (investigators), others who are reviewing it to make sure that it's clean (data managers), and also people who are stuck in the middle (clinical monitors). Of course there are many other types of users, but this is just a subset to illustrate the point. These different groups of users all serve a particular purpose relating to the overall collection of data and success of the study. When the data looks problematic or unclean, the data managers will flag it for review, which the clinical monitors can act on.

What's unique about the way that life sciences deals with this is that they've set up complex systems and rules to make sure that the whole system runs well. The tools associated around these processes help augment human intuition through alerting, automated dissemination and automatic feedback. The questions aren't necessarily known at the beginning of a trial, but as the data is collected, new questions evolve and the tools and processes in place are built to handle the changing landscape.

No matter what the purpose of Big Data analytics, any organization can benefit from the mindset of cloud-based analytics as a tool that needs to consistently be adjusted and refined to meet the needs of users.

Ongoing Challenges of Big Data Analytics
Given this history with data, one would expect that drug and device developers would be light years ahead when it comes to leveraging Big Data technologies - especially given that the collection and analytics of clinical data is often a matter of life and death. But while they have much more experience with data, the truth is that life sciences organizations are just now starting to integrate analytics technologies that will enable them to work with that data in new, more efficient ways - no longer involving billions of dollars a year, countless statisticians, archaic methods, and, if we're being honest, brute force. As new technology becomes available, the industry will continue to become more and more seamless. In the meantime, other industries looking to wrap their heads around the Big Data challenge should look to life sciences as the starting point for best practices in understanding how and when to ask the right questions, monitoring data along the way and selecting tools that improve the user experience.

More Stories By Rick Morrison

Rick Morrison is CEO and co-founder of Comprehend Systems. Prior to Comprehend Systems, he was the Chief Technology Officer of an Internet-based data aggregator, where he was responsible for product development and operations. Prior to that, he was at Integrated Clinical Systems, where he led the design and implementation of several major new features. He also proposed and led a major infrastructure redesign, and introduced new, streamlined development processes. Rick holds a BS in Computer Science from Carnegie Mellon University in Pittsburgh, Pennsylvania.

Comments (0)

Share your thoughts on this story.

Add your comment
You must be signed in to add a comment. Sign-in | Register

In accordance with our Comment Policy, we encourage comments that are on topic, relevant and to-the-point. We will remove comments that include profanity, personal attacks, racial slurs, threats of violence, or other inappropriate material that violates our Terms and Conditions, and will block users who make repeated violations. We ask all readers to expect diversity of opinion and to treat one another with dignity and respect.


Cloud Expo Breaking News
All too many discussions about DevOps conclude that the solution is an all-purpose player: developer and operations guru, complete with pager for round-the-clock duty. For most organizations that is not the way forward. In his session at DevOps Summit, Bernard Golden, Vice President of Strategy at ActiveState, will discuss how to achieve the agility and speed of end-to-end automation without requiring an organization stocked with Supermen and Superwomen.
The Internet of Things promises to transform businesses (and lives), but navigating the business and technical path to success can be difficult to understand. In his session at 15th Internet of @ThingsExpo, Chad Jones, Vice President, Product Strategy of LogMeIn's Xively IoT Platform, will show you how to approach creating broadly successful connected customer solutions using real world business transformation studies including New England BioLabs and more.
“The Internet of Things is a wave that has arrived and it’s growing really fast. The concern at Aria Systems is making sure that people understand the ramifications of their attempts to monetize whatever it is they build on the Internet of Things," explained C Brendan O’Brien, Co-founder and Chief Architect at Aria Systems, in this SYS-CON.tv interview at the Internet of @ThingsExpo, held June 10-12, 2014, at the Javits Center in New York City. Internet of @ThingsExpo 2014 Silicon Valley, November 4–6, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading IoT industry players in the world.
“About two years ago Brother launched a new group called Brother Online. We thought it was a good idea for a hardware company to get into the cloud services market and our first step into that market was web conferencing,” explained Courtney Behrens, Senior Marketing Manager at Brother International, in this SYS-CON.tv interview at the 14th International Cloud Expo®, held June 10-12, 2014, at the Javits Center in New York City. Cloud Expo® 2014 Silicon Valley, November 4–6, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading Cloud industry players in the world.
"So many teams have been stuck in their own practices for the last ten years and it's really hard to sell all the latest and greatest tools, but the reality is all the tools around operations have evolved so much you are starting to see a big shift toward upgrading that tool set, focusing more on automation, more on cloud," explained Dustin Whittle, Developer Evangelist at AppDynamics, in this SYS-CON.tv interview at the DevOps Summit, held June 10-12, 2014, at the Javits Center in New York City.
“We provide disaster recovery services as well as solutions. We also provide back-up solutions that work across your internal on-premise assets as well as in the public and private cloud," stated Joel Ferman, Vice President of Marketing at InMage Systems, in this SYS-CON.tv interview at the 14th International Cloud Expo® (http://www.CloudComputingExpo.com/), held June 10-12, 2014, at the Javits Center in New York City. Cloud Expo® 2014 Silicon Valley, November 4–6, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading Cloud industry players in the world.
SYS-CON Events announced today that Harbinger Systems will exhibit at SYS-CON's 15th International Cloud Expo®, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Harbinger Systems is a global company providing software technology services. Since 1990, Harbinger has developed a strong customer base worldwide. Its customers include software product companies ranging from hi-tech start-ups in Silicon Valley to leading product companies in the US and large in-house IT organizations.
“Distrix fits into the overall cloud and IoT model around software-defined networking. There’s a broad category around software-defined networking that’s focused on data center, and we focus on the WAN,” explained Jay Friedman, President of Distrix, in this SYS-CON.tv interview at the Internet of @ThingsExpo, held June 10-12, 2014, at the Javits Center in New York City. Internet of @ThingsExpo 2014 Silicon Valley, November 4–6, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading IoT industry players in the world.
“Dell Cloud Manager is a cloud management environment for the consumption of cloud resources and we provide a consistent interface, both in terms of API and in terms of user interface for doing a wide variety of activities core to deploying and operating software in cloud," explained James Urquhart, Technologist & Director of Cloud Management Solutions at Dell, in this SYS-CON.tv interview at the 14th International Cloud Expo®, held June 10-12, 2014, at the Javits Center in New York City. Cloud Expo® 2014 Silicon Valley, November 4–6, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading Cloud industry players in the world.
SYS-CON Events announced today that the Cloud Standards Customer Council (CSCC ) has been named “Media Sponsor” of SYS-CON's 15th International Cloud Expo®, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. The Cloud Standards Customer Council is an end user advocacy group dedicated to accelerating cloud's successful adoption, and drilling down into the standards, security and interoperability issues surrounding the transition to the cloud. The Council will provide cloud users with the opportunity to drive client requirements into standards development organizations and deliver materials such as best practices and use cases to assist other enterprises.
“Ambernet Technologies is an innovative software company and we’ve been very focused on building enterprise grade cloud management and cloud brokerage software," explained Troy Halford, CSO of Ambernet Technologies, in this SYS-CON.tv interview at the 14th International Cloud Expo®, held June 10-12, 2014, at the Javits Center in New York City. Cloud Expo® 2014 Silicon Valley, November 4–6, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading Cloud industry players in the world.
“We introduced our product called AgilData. It’s basically the first Agile view, a streaming view of looking at a database and data as a streaming real-time dynamic capability," explained Cory Isaacson, CEO/CTO of CodeFutures Corporation, in this SYS-CON.tv interview at the 14th International Cloud Expo®, held June 10-12, 2014, at the Javits Center in New York City. Cloud Expo® 2014 Silicon Valley, November 4–6, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading Cloud industry players in the world.
“As the move to the cloud started, we stayed ahead of that by providing security solutions to our enterprise customers, financial customers, and now a whole new range of customers, which are application developers," explained John Gunn, VP of Corporate Communications for VASCO Data Security, in this SYS-CON.tv interview at the 14th International Cloud Expo®, held June 10-12, 2014, at the Javits Center in New York City. Cloud Expo® 2014 Silicon Valley, November 4–6, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading Cloud industry players in the world.
The industry is heated with debates on whether adopting private or public cloud is the smartest, best, cheapest, you name it choice. But this debate is missing the mark. Businesses shouldn’t be discussing public vs. private, but rather how can they make the two work together to their greatest advantage. The ideal is to merge on-premise and off-premise into a seamless environment that can be managed as a single entity – a forward-looking stance that will eventually see major adoption. But as of late 2013, hybrid cloud was still “rare,” noted Gartner analyst Tom Bittman. In his session at 15th Cloud Expo, Marten Mickos, CEO of Eucalyptus Systems, will discuss how public clouds need on-premise satellites to win and, conversely, how on-premise environments cannot be really powerful unless they are connected to the public cloud. It’s not two competing worlds; it’s two dimensions of the same world.
SYS-CON Events announced today that the Wall Street Technology Association (WSTA) has been named "Association Sponsor" of SYS-CON's 15th International Cloud Expo®, which will take place on November 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. The Wall Street Technology Association (WSTA®) provides financial industry technology professionals, vendors, service providers, and consultants with forums to learn from and connect with each other. The WSTA facilitates seminars and networking events where members meet and exchange ideas and best practices that assist them in effectively capitalizing on technology advances and dealing with financial industry business challenges. Founded in 1967, the WSTA is a not-for-profit association with a long history of evolving to meet the needs of its members.